Kynam Capital Management, LP Sutro Biopharma, Inc. Transaction History
Kynam Capital Management, LP
- $837 Million
- Q2 2025
A detailed history of Kynam Capital Management, LP transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 5,088,099 shares of STRO stock, worth $4.48 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
5,088,099
Previous 5,441,447
6.49%
Holding current value
$4.48 Million
Previous $3.54 Million
2.15%
% of portfolio
0.43%
Previous 0.3%
Shares
10 transactions
Others Institutions Holding STRO
# of Institutions
106Shares Held
59.2MCall Options Held
92.8KPut Options Held
0-
Black Rock Inc. New York, NY6.91MShares$6.08 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.49MShares$5.71 Million0.16% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.73MShares$4.16 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.12MShares$3.62 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA3.06MShares$2.69 Million3.73% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $45.9M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...